Agreements reached under this partnership
Capital and Business Alliance- 1
We will combine our capabilities in identifying and evaluating opportunities, building businesses, raising funds and leveraging our global network with OEP's investment, research and development, manufacturing, sales and commercialisation capabilities and business base in the Asia-Pacific region, further strengthening our investment business capabilities from identifying investment opportunities through to the commercialisation and growth of portfolio companies.
- 2
By leveraging the strengths of both companies, we aim to connect outstanding technologies in Japan, Taiwan and elsewhere with global markets and create new business opportunities in the healthcare sector.
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
| Item | Details |
|---|---|
| Name of alliance partner | Orient EuroPharma Co., Ltd. |
| Alliance partner's business activities | Manufacture and sale of pharmaceuticals, health and nutritional foods, cosmetics, etc. |
| Alliance partner's location | Taipei City, Taiwan |
| Alliance partner's capital | 867 million Taiwan dollars |
| Type of alliance | Capital and Business Alliance |
| Details of the alliance | We will combine our capabilities in identifying and evaluating opportunities, building businesses, raising funds and leveraging our global network with OEP's investment, research and development, manufacturing, sales and commercialisation capabilities and business base in the Asia-Pacific region, further strengthening our investment business capabilities from identifying investment opportunities through to the commercialisation and growth of portfolio companies., By leveraging the strengths of both companies, we aim to connect outstanding technologies in Japan, Taiwan and elsewhere with global markets and create new business opportunities in the healthcare sector. |
| Date of board resolution | 17 September 2026 |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To create new businesses and drive further growth by combining our management expertise, ability to identify opportunities, business-building capabilities, fundraising capabilities and global network with OEP's investment, research and development, manufacturing, sales and commercialisation capabilities and business base in the Asia-Pacific region, founded on our longstanding track record of collaboration and relationship of trust.